Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D Wu

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
BMC Medical Genomics|January 26, 2011
Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samplesSerban Nacu, Wenlin Yuan, Zhengyan Kan, et al.
AIDS (London, England)|March 28, 2003
Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitorsMatthew J Gonzales, Thomas D Wu, Jonathan Taylor, et al.
Journal of Virology|March 29, 2003
Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatmentsThomas D Wu, Celia A Schiffer, Matthew J Gonzales, et al.
Plos One|May 12, 2011
TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including gliomaKui Lin, James R Taylor, Thomas D Wu, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapiesAmy A Lo, Andrew Wallace, Daniel Oreper, et al.
Bioinformatics (Oxford, England)|April 10, 2004
GEPIS--quantitative gene expression profiling in normal and cancer tissuesYan Zhang, David A Eberhard, Gretchen D Frantz, et al.
Nature Cancer|January 17, 2025
Publisher Correction: TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulationKatherine Nutsch, Karl L Banta, Thomas D Wu, et al.
Plos Pathogens|June 29, 2016
Two Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding AntibodyNing Chai, Lee R Swem, Mike Reichelt, et al.
Nature Cancer|December 16, 2024
TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulationKatherine Nutsch, Karl L Banta, Thomas D Wu, et al.
Molecular Cancer Research : MCR|April 18, 2009
Genetic alterations and oncogenic pathways associated with breast cancer subtypesXiaolan Hu, Howard M Stern, Lin Ge, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
BMC Medical Genomics|January 26, 2011
Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samplesSerban Nacu, Wenlin Yuan, Zhengyan Kan, et al.
AIDS (London, England)|March 28, 2003
Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitorsMatthew J Gonzales, Thomas D Wu, Jonathan Taylor, et al.
Journal of Virology|March 29, 2003
Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatmentsThomas D Wu, Celia A Schiffer, Matthew J Gonzales, et al.
Plos One|May 12, 2011
TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including gliomaKui Lin, James R Taylor, Thomas D Wu, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapiesAmy A Lo, Andrew Wallace, Daniel Oreper, et al.
Bioinformatics (Oxford, England)|April 10, 2004
GEPIS--quantitative gene expression profiling in normal and cancer tissuesYan Zhang, David A Eberhard, Gretchen D Frantz, et al.
Nature Cancer|January 17, 2025
Publisher Correction: TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulationKatherine Nutsch, Karl L Banta, Thomas D Wu, et al.
Plos Pathogens|June 29, 2016
Two Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding AntibodyNing Chai, Lee R Swem, Mike Reichelt, et al.
Nature Cancer|December 16, 2024
TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulationKatherine Nutsch, Karl L Banta, Thomas D Wu, et al.
Molecular Cancer Research : MCR|April 18, 2009
Genetic alterations and oncogenic pathways associated with breast cancer subtypesXiaolan Hu, Howard M Stern, Lin Ge, et al.
Pageof 6